Person-centric clinical trials: An opportunity for the good clinical practice (GCP)-practice-based research network

Journal of Clinical Pharmacology

Volumn 53, Issue 10, 2013, Pages 1091-1094

  Curro, Frederick A ^a   Robbins, Dennis A ^b,c   Millenson, Michael L ^d   Chester, H C ^e   Naftolin, Frederick ^f  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^b Integrated Decisions Ethics Alternatives and Solutions   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cer; Clinical research; Gcp; Patient centered; Patient centric; Pbrn; Person centricity

Indexed keywords

PLACEBO;

ADVERSE OUTCOME; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DRUG EFFECT; DRUG INDUSTRY; DRUG INTERACTION; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; GOOD CLINICAL PRACTICE; HUMAN; MEDICAL ETHICS; PATIENT PARTICIPATION; PERSONALIZED MEDICINE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CER; CLINICAL RESEARCH; GCP; PATIENT-CENTERED; PATIENT-CENTRIC; PBRN; PERSON-CENTRICITY;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT-CENTERED CARE; RESEARCH DESIGN;

EID: 84885161730     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.138     Document Type: Article

References (10)

1. American Academy of Family Practice, Robert Graham Center. The patient centered medical home: history, seven core features, evidence and transformational change. Washington, DC: Robert Graham Center, November 2007. Accessed at www.graham-center.org.
2. The American Recovery and Reinvestment Act of 2009. H.R. 2009. At: www.gpo.gov/fdsys/pkg/PLAW-111publ5/content-detail.html Accessed on July 11, 2011.
3. Robbins DA, Curro FA, Fox CH. Defining patient-centricity: opportunities, challenges and implications for clinical care and research. Ther Innov Regul Sci. 2013;47(3):349-355.
4. Curro FA, Thompson VP, Naftolin F, et al. Practice-based research network infrastructure design for institutional review board risk assessment and generalizability of clinical results. Ther Innov Regul Sci. 2013;47(1):82-89.
5. Curro FA, Vena D, Naftolin F, Terracio L, Thompson VP. The PBRN initiative: transforming new technologies to improve patient care. J Dental Res. 2012;91(7 suppl.):S12-S20.
6. Institute of Medicine. Observational Studies in Learning a Health Care System. Workshop presented at the National Academy of Sciences, Washington, DC, April 2, 2013.
7. Food and Drug Administration. Guidance for industry. Patientreported outcome measures: use in medical product development to support labeling claims; 2009. URL at: www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf Accessed on October 4, 2012.
8. International Conference on Harmonization. ICH E10. Choice of control group and related issues in clinical trials, from http://www.fda.gov/ RegulatoryInformation/Guidances/ucm125802.htm Accessed on October 26, 2009.
9. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med. 2000;133:455-463.
10. Clancy C, Collins FS. Patient-centered outcomes research institute: The intersection of science and health care. Sci Transl Med. 2010;2: (37): 18.